Chronic administration of anabolic steroids disrupts pubertal onset and estrous cyclicity in rats

Biology of Reproduction

Volumn 68, Issue 2, 2003, Pages 465-471

  Clark, Ann S ^a   Kelton, Megan C ^a   Whitney, Andrew C ^a  

^a DARTMOUTH COLLEGE   (United States)

Author keywords

Androgen receptor; Mechanisms of hormone action; Puberty; Steroid hormones; Vagina

Indexed keywords

ANABOLIC AGENT; ANDROGEN; FLUTAMIDE; METANDIENONE; METHYLTESTOSTERONE; STANOZOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG UTILIZATION; ESTRUS CYCLE; FEMALE; FEMALE GENITAL SYSTEM; HORMONE ACTION; LONG TERM EXPOSURE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PUBERTY; RAT; VAGINA;

ANABOLIC AGENTS; ANDROGEN ANTAGONISTS; ANIMALS; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ESTRUS; FEMALE; FLUTAMIDE; METHANDROSTENOLONE; METHYLTESTOSTERONE; PREGNANCY; RATS; RATS, LONG-EVANS; RECEPTORS, ANDROGEN; SEXUAL MATURATION; STANOZOLOL; TIME FACTORS; VAGINA;

ANIMALIA;

EID: 0037305613     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.008078     Document Type: Article

References (54)

1. Honour JW. Steroid abuse in female athletes. Curr Opin Obstet Gynecol 1997; 9:181-186.
2. Malarkey WB, Strauss RH, Leizman DJ, Liggett MT, Demers LM. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obstet Gynecol 1991; 165:1385-1390.
3. Strauss RH, Liggett MT. Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 1985; 253: 2871-2873.
4. Strauss RH, Yesalis CE. Additional effects of anabolic steroids on women. In: Yesalis CE (ed.), Anabolic Steroids in Sport and Exercise. Champaign, IL: Human Kinetics; 1993: 151-160.
5. Blasberg ME, Langan CJ, Clark AS. The effects of 17α-methyltestosterone, methandrostenolone, and nandrolone decanoate on the rat estrous cycle. Physiol Behav 1997; 61:265-272.
6. Bronson FH. Effects of prolonged exposure to anabolic steroids on the behavior of male and female mice. Pharmacol Biochem Behav 1996; 53:329-334.
7. Bronson FH, Nguyen KQ, De La Rosa J. Effect of anabolic steroids on behavior and physiological characteristics of female mice. Physiol Behav 1996; 59:49-55.
8. Clark AS, Blasberg ME, Brandling-Bennett EM. Stanozolol, oxymetholone, and testosterone cypionate effects on the rat estrous cycle. Physiol Behav 1998; 63:287-295.
9. Yesalis CE, Barsukiewicz CK, Kopstein AN, Bahrke MS. Trends in anabolic-androgenic steroid use among adolescents. Arch Pediatr Adolesc Med 1997; 151:1197-1206.
10. Elliot DL, Goldberg L. Women and anabolic steroids. In: Yesalis CE (ed.), Anabolic Steroids in Sport and Exercise, 2nd ed. Champaign, IL: Human Kinetics; 2000: 225-246.
11. Irving LM, Wall M, Neumark-Sztainer D, Story M. Steroid use among adolescents: findings from Project EAT. J Adolesc Health 2002; 30: 243-252.
12. Ojeda SR, Urbanski HF. Puberty in the rat. In: Knobil E, Neil JD (eds.), The Physiology of Reproduction, 2nd ed. New York: Raven Press; 1994: 363-409.
13. Whitney AC, Clark AS. Effects of acute stanozolol on puberty in female rats. Biol Reprod 2001; 64:1460-1465.
14. Gruber AL, Pope HG. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000; 69: 19-26.
15. Blasberg ME, Robinson S, Henderson LP, Clark AS. Inhibition of estrogen-induced sexual receptivity by androgens: role of the androgen receptor. Horm Behav 1998; 34:283-293.
16. U.S. Public Health Services. Guide for the Care and Use of Laboratory Animals Institute of Laboratory Animal Resources, Commission on Life Sciences. Washington. DC: National Academy Press; 1996.
17. Firlit MG, Schwartz NB. Uncoupling of vaginal opening and the first ovulation - an indication of an alteration in the pituitary-gonadal axis. Biol Reprod 1977; 16:441-444.
18. Everett JW. Neurobiology of reproduction in the female rat. Monogr Endocrinol 1989; 32:1-133.
19. Whitney AC, Clark AS. Stanozolol disrupts the onset of puberty in the female rat. Soc Neurosci Abstr 1999; 25:612.
20. Korkia P, Lenehan P, McVeigh J. Non-medical use of androgens among women. J Perform Enhanc Drugs 1996; 1:71-76.
21. Saartok T, Dahlberg E, Gustafsson J. Relative binding affinities of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology 1984;114:2100-2106.
22. Witta B, Artis A, Ackerman DM, Longcope C. Binding of 17α-methyltestosterone in vitro to human sex hormone binding globulin and rat ventral prostate androgen receptors. Ther Drug Monit 1995; 17:377-380.
23. Zarrow MX, Naqvi RH, Denenberg VH. Androgen-induced precocious puberty in the female rat and its inhibition by hippocampal lesions. Endocrinology 1969; 84:14-19.
24. Okazaki K, Imazawa T, Nakamura H, Furukawa F, Nishikawa A, Hirose M. A repeated 28-day oral dose toxicity study of 17α-methyltestosterone in rats, based on the 'Enhanced OECD Test Guideline 407' for screening the endocrine-disrupting chemicals. Arch Toxicol 2001; 75:635-642.
25. Bates PC, Chew LF, Millward DJ. Effects of anabolic steroid stanozolol on growth and protein metabolism in the rat. J Endocrinol 1987; 114:373-381.
26. O'Connor JC, Cook JC, Slone TW, Makovec T, Frame SR, Davis LG. An ongoing validation of a tier I screening battery for detecting endocrine-active compounds (EACs). Toxicol Sci 1998; 26:45-60.
27. Toyoda K, Shibutani M, Tamura T, Koujitani T, Uneyama C, Hirtose M. Repeated dose (28 days) oral toxicity study of flutamide in rats, based on the draft protocol for the 'Enhanced OECD Test Guideline 407' for screening for endocrine-disrupting chemicals. Arch Toxicol 2000; 74:127-132.
28. Brann DW, Putnam CD, Mahesh VB. Similarities and differences in progesterone and androgens in modulation of LH, FSH, and PRL release: unexpected properties of flutamide. J Steroid Biochem 1990; 36:287-294.
29. Kim SK, Shin J, Moon HJ, Kim TS, Kang IH, Seok J, Kim IY, Park KL, Han SY. Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone and flutamide. Toxicol Sci 2002; 67:52-62.
30. Wakeling AE, Bowler J. ICI 182,780, a new antioestrogen with clinical potential. J Steroid Biochem Molec Biol 1992; 43:173-177.
31. Friedl KE. Effect of anabolic steroid use on body composition and physical performance. In: Yesalis CE (ed.), Anabolic Steroids in Sport and Exercise, 2nd ed. Champaign, IL: Human Kinetics; 2000: 175-223.
32. Zmuda JM, Fahrebach MC, Younkin BT, Bausserman LL, Terry RB, Catlin DH, Thompson PD. The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. Metabolism 1993; 42:446-450.
33. Wang H, Eriksson H, Sahlin L. Estrogen receptors α and B in the female reproductive tract of the rat during the estrous cycle. Biol Reprod 2000; 63:1331-1340.
34. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. Antagonists selective for estrogen receptor α. Endocrinology 2002; 143:941-947.
35. Knudsen JF, Mahesh VB. Initiation of precocious sexual maturation in the immature rat treated with dehydroepiandrosterone. Endocrinology 1975; 97:458-468.
36. Lephart ED, Mathews D, Noble JF, Ojeda SR. The vaginal epithelium of immature rats metabolizes androgens through an aromatase-like reaction: changes during the time of puberty. Biol Reprod 1989; 40: 259-267.
37. Mathews D, Andrews WW, Parker R, Ojeda SR. A role for aromatizable androgens in female rat puberty. Biol Reprod 1987; 36:836-843.
38. Lyon MF, Glenister PH. Evidence from Tfm/0 that androgen is inessential for reproduction in female mice. Nature 1974; 247:366-367.
39. Clark AS, Barber DM. Anabolic-androgenic steroids and aggression in castrated male rats. Physiol Behav 1994; 56:1107-1113.
40. Clark AS, Fast AF. Comparison of the effects of 17α-methyltestosterone, methandrostenolone, and nandrolone decanoate on the sexual behavior of castrated male rats. Behav Neurosci 1996; 110:1476-1486.
41. Clark AS, Harrold EV, Fast AF. Anabolic-androgenic steroid effects on the sexual behavior of intact male rats. Horm Behav 1997; 31:35-46.
42. Clark AS, Harrold EV. Comparison of the effects of stanozolol, oxymetholone, and testosterone cypionate on the sexual behavior of castrated male rats. Behav Neurosci 1997; 111:1368-1374.
43. Kumar K, Sundaram K, Bardin CW. Feedback regulation of gonadotropins by androgens in rats: is 5α-reduction involved. J Steroid Biochem Molec Biol 1995; 52:105-112.
44. Sodersten P, Gray G, Damassa DA, Smith ER, Davidson JM. Effects of a non-steroidal anti-androgen on sexual behavior and pituitary-gonadal function in the male rat. Endocrinology 1975; 97:1468-1475.
45. Mahesh VB, Mills TM, Bagnell CA, Conway BA. Animal models for study of polycystic ovaries and ovarian atresia. Adv Exp Med Biol 1987; 219:237-257.
46. Tetsuka M, Hillier SG. Differential regulation of aromatase and androgen receptor in granulosa cells. J Steroid Biochem Mol Biol 1997; 61:233-239.
47. Giguere V, Lefebvre F-A, Labrie F. Androgens decrease LHRH binding sites in rat anterior pituitary in culture. Endocrinology 1981; 108: 350-352.
48. Turgeon JL, Waring DW. Androgen modulation of luteinizing hormone secretion by female rat gonadotropes. Endocrinology 1999; 140: 1767-1774.
49. Brown TJ, Adler GH, Sharma M, Hochberg RB, MacLusky NJ. Androgen treatment decreases estrogen receptor binding in the ventromedial hypothalamus of the rat brain: a quantitative in vivo autoradiographic analysis. Mol Cell Neurosci 1994; 5:549-555.
50. Zamorano P, Steinsapir J, Mahesh VB. Effect of 5α-dihydrotestosterone and dexamethasone on estrogen receptors in the anterior pituitary and uterus. Steroids 1992; 57:18-26.
51. Snyder BW, Beecham GD, Winneker RC. Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component. Fertil Steril 1989; 51:705-710.
52. Snyder BW, Beecham GD, Winneker RC. Danazol suppression of luteinizing hormone in the rat: evidence for mediation by both androgen and estrogen receptors. Proc Soc Exp Biol Med 1990; 194:54-57.
53. Baker, J. A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents. J Voice 1999; 13:496-507.
54. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997; 43:1262-1279.